Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome
Human Cell · 2024
DOI: 10.1007/s13577-024-01059-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Zhenfeng Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1st Minde Road, Jiangxi, 330006, Nanchang, China. Hauptthemen laut MEDLINE: Pioglitazone, Reperfusion Injury, NLR Family, Pyrin Domain-Containing 3 Protein, Acute Kidney Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, National Natural Science Foundation of China, Hengrui Diabetes Metabolism Research Fund.
Abstract (Originalsprache)
Acute kidney injury (AKI) induced by renal ischemia/reperfusion injury (IRI) is a severe clinical condition. ROS accumulation, antioxidant pathways deficiency, and inflammation are involved in IRI. Pioglitazone (Pio) exerts anti-inflammatory and antioxidant effects. The aim of this study was to explore the protective effects of pioglitazone against IRI-induced AKI. Pathogen-free Sprague-Dawley (SD) rats were arbitrarily divided into four groups: Sham operation group Control (CON) group, CON + Pio group, I/R + Saline group, and I/R + Pio group. In addition, HK-2 cells were subjected to hypoxia and reoxygenation to develop an H/R model for investigation of the protective mechanism of Pio. Pretreatment with pioglitazone in the model rats reduced urea nitrogen and creatinine levels, histopathological scores, and cytotoxicity after IRI. Pioglitazone treatment significantly attenuated renal cell apoptosis, decreased cytotoxicity, increased Bcl-2 expression, and downregulated Bax expression. Besides, the levels of ROS and inflammatory factors, including NLRP3, ASC, pro-IL-1β, pro-caspase-1, cleaved-caspase-1, TNF-α, IL-6, and IL-1β, in I/R rats and H/R cells were normalized by the pioglitazone treatment. Pioglitazone improved IRI-induced AKI by attenuating oxidative stress and NLRP3 inflammasome activation. Therefore, pioglitazone has the potential to serve as a novel agent for renal IRI treatment and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1st Minde Road, Jiangxi, 330006, Nanchang, China.
- Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Jiangxi, 330006, Nanchang, China.
- The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Jiangxi, Nanchang, China.
- School of Ophthalmology and Optometry, Jiangxi Medical College, Nanchang University, Jiangxi, Nanchang, China.
- Department of Endocrinology and Metabolism, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Jiangxi, 330006, Nanchang, China.
- Institute for the Study of Endocrinology and Metabolism in Jiangxi Province, Jiangxi, 330006, Nanchang, China.
Förderung
- Natural Science Foundation of Jiangxi Province
- National Natural Science Foundation of China
- Hengrui Diabetes Metabolism Research Fund
- Jiangxi Province Thousands of Plans
- Natural Science Foundation in Jiangxi Province
Zitieren
APA
Ye, Z., Zhang, J., Xu, Z., Li, Z., Huang, G., Tong, B., Xia, P., Shen, Y., Hu, H., Yu, P., & Xi, X. (2024). Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome. Human Cell. https://doi.org/10.1007/s13577-024-01059-w
Vancouver
Ye Z, Zhang J, Xu Z, Li Z, Huang G, Tong B, et al. Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome. Human Cell. 2024. doi:10.1007/s13577-024-01059-w
BibTeX
@article{Ye2024,
author = {Ye, Zhenfeng and Zhang, Jing and Xu, Zhou and Li, Zhangwang and Huang, Gaomin and Tong, Bin and Xia, Panpan and Shen, Yunfeng and Hu, Honglin and Yu, Peng and Xi, Xiaoqing},
title = {Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01059-w}
}
EUVIMED